The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of RHD.
Rheumatic heart disease (RHD) is a preventable non-communicable condition that disproportionately affects the world's poorest and most vulnerable. The World Heart Federation Roadmap for improved RHD control is a resource designed to help a variety of stakeholders raise the profile of RHD nationally and globally, and provide a framework to guide and support the strengthening of national, regional and global RHD control efforts. The Roadmap identifies the barriers that limit access to and uptake of proven interventions for the prevention and control of RHD. It also highlights a variety of established and promising solutions that may be used to overcome these barriers. As a general guide, the Roadmap is meant to serve as the foundation for the development of tailored plans of action to improve RHD control in specific contexts.
ECOHOST -The Centre for Health and Social Change, Faculty of Public Health & Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom. Electronic address: benjamin.palafox@lshtm.ac.uk.
Benjamin
B
Palafox
Instituto Nacional de Saúde, Ministério da Saúde and Universidade Eduardo Mondlane, Maputo, Moçambique.
Ana Olga
AO
Mocumbi
Amrita Institute of Medical Sciences and Research Centre, Cochin, Kerala, India.
R Krishna
RK
Kumar
University of Khartoum and Sudan Heart Center, Khartoum, Sudan.
Sulafa K M
SKM
Ali
Fiji RHD Prevention and Control Project, Ministry of Health and Medical Services and Cure Kids New Zealand, Suva, Fiji.
Elizabeth
E
Kennedy
College of Health Sciences, Jimma University, Jimma, Ethiopia.
Abraham
A
Haileamlak
Department of Medicine, University of Washington, Seattle, WA, USA; Department of Medicine, University of Cape Town, Cape Town, South Africa.
David
D
Watkins
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kadia
K
Petricca
Telethon Kids Institute, Perth, Western Australia, Australia.
Rosemary
R
Wyber
Ministry of Health & Medical Services, Tarawa, Kiribati.
Patrick
P
Timeon
World Heart Federation, Geneva, Switzerland.
Jeremiah
J
Mwangi
D003266:Continuity of Patient Care / Q000592:standards; D017281:Cost of Illness; D019353:Endemic Diseases / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005260:Female; D006297:Health Services Accessibility / Q000592:standards; D006801:Humans; D008297:Male; D010401:Penicillin G Benzathine / Q000600:supply & distribution / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011314:Preventive Health Services / Q000592:standards; D011322:Primary Prevention / Q000592:standards; D012213:Rheumatic Fever / Q000401:mortality / Q000517:prevention & control; D012214:Rheumatic Heart Disease / Q000401:mortality / Q000517:prevention & control*; D012307:Risk Factors; D055502:Secondary Prevention / Q000592:standards
D010401:Penicillin G Benzathine